1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967; 16:178–222.
2. Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. I Infect. 2013; 67:1–10.
Article
3. Lee KY, Han ]W, Lee IS. Kawasaki disease may be a hyperim-mune reaction of genetically susceptible children to variants of normal environmental flora. Med Hypotheses. 2007; 69:642–51.
4. Lee KY, Rhim JW, Kang JH. Kawasaki disease: laboratory findings and an immunopathogenesis on the premise. Yonsei Med J. 2012; 53:262–75.
5. American Academy of Pediatrics. Influenza. Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. editors.2012 Red book: Report of the Committee on infectious diseases. 29th Ed.Elk Grove Village, IL: American Academy of Pediatrics;2012. p. 439–53.
6. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004; 17:697–728.
7. Huang X, Huang P, Zhang L, Xie X, Xia S, Gong F, et al. In-fluenza infection and Kawasaki disease. Rev Soc Bras Med Trop. 2015; 48:243–8.
8. Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005; 191:499–502.
Article
9. Okano M, Thiele GM, Sakiyama Y, Matsumoto S, Purtilo DT. Adenovirus infection in patients with Kawasaki disease. IMed Virol. 1990; 32:53–7.
Article
10. Burns JC, Geha RS, Schneeberger EE, Newburger JW, Rosen FS, Glezen LS, et al. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature. 1986; 323:814–6.
Article
11. Iwanaga M, Takada K, Osato T, Saeki Y, Noro S, Sakurada N. Kawasaki disease and Epstein–Barr Virus. Lancet. 1981; 1:938–9.
Article
12. Kikuta H, Matsumoto S, Osato T. Kawasaki disease and Epstein–Barr Virus. Acta Paediatr Jpn. 1991; 33:765–70.
Article
13. Kato H, Fujimoto T, Inoue O, Kondo M, Koga Y, Yamamoto S, et al. Variant strain of Propjonjbacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet. 1983; 2:1383–8.
14. Ohtaki C, Tomiyama T, Suzuki M, Hayakawa H, Kaga M. Leptospiral antibody and MLNS. J Pediatr. 1978; 93:896.
Article
15. Shinomiya N, Takeda T, Kuratsuji T, Takagi K, Kosaka T, Tatsuzawa O, et al. Variant Streptococcus sanguis as an etiological agent of Kawasaki disease. Prog Clin Biol Res. 1987; 250:571–2.
16. Leahy TR, Cohen E, Allen UD. Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneu-monia: a case report. Can J Infect Dis Med Microbiol. 2012; 23:137–9.
17. Cho SY, Cho HK, Cho KY, Kim HS, Sohn SJ. Kawasaki disease presenting as retropharyngeal abscess. Korean J Pediatr. 2008; 51:1023–7.
Article
18. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, et al. Selective expansion of T cells expressing T–cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA. 1992; 89:4066–70.
Article
19. Mancia L, Wahlstrbm J, Schiller B, Chini L, Blinder G, D'Argenio P, et al. Characterization of the T–cell receptor V-beta repertoire in Kawasaki disease. Scand J Immunol. 1998; 48:443–9.
Article
20. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002; 140:742–6.
Article
21. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Oka-jima Y, et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. j Infect Dis. 1995; 172:558–61.
Article
22. Greco F, Sorge A, Salvo V, Sorge G. Cutaneous vasculitis associated with Mycoplasma pneumoniae infection: case report and literature review. Clin Pediatr. 2007; 46:451–3.
23. Lee MN, Cha JH, Ahn HM, Yoo JH, Kim HS, Sohn SJ, et al. Mycoplasma pneumoniae infection in patients with Kawasaki disease. Korean J Pediatr. 2011; 54:122–6.
24. Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2012; 55:42–7.
25. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumo-niae in Korean children: the epidemiology of pneumonia over an 18–year period. J Infect. 2008; 56:326–31.
26. Rowley AH, Baker SC, Shulman ST, Fox LM, Takahashi K, Garcia FL, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005; 192:1757–66.
Article
27. Rodo X, Ballester J, Cayan D, Melish ME, Nakamura Y, Uehara R, et al. Association of Kawasaki disease With tropospheric wind patterns. Sci Rep. 2011; 1:152.
Article
28. Lee KY. A common immunopathogenesis mechanism for infectious diseases: the protein–homeostasis–system hypothesis. Infect Chemother. 2015; 47:12–26.
Article
29. Jordan–Villegas A, Chang ML, Ramilo O, Mejias A. Concomitant respiratory Viral infections in children with Kawasaki disease. Pediatr Infect Dis J. 2010; 29:770–2.